08.05.2014 Views

registration document France Telecom 2009 - Orange.com

registration document France Telecom 2009 - Orange.com

registration document France Telecom 2009 - Orange.com

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

26 REPORT<br />

2010 shareholders’ meeting<br />

OF THE BOARD OF DIRECTORS OF FRANCE TELECOM ON RESOLUTIONS SUBMITTED<br />

TO THE ANNUAL SHAREHOLDERS’ MEETING - FINANCIAL YEAR <strong>2009</strong><br />

Twelfth resolution<br />

Issue, free of charge, of option-related liquidity<br />

instruments reserved for holders of <strong>Orange</strong> S.A.<br />

share subscription options having signed a liquidity<br />

contract with the Company<br />

In order to simplify the payment of consideration in cash or in<br />

<strong>France</strong> <strong>Tele<strong>com</strong></strong> shares under the implementation of liquidity<br />

contracts described in the previous resolution and under<br />

resolutions voted annually by your Shareholders’ Meeting since<br />

2005, the free allocation of option-based liquidity instruments<br />

(“ILO”), <strong>com</strong>prised of warrants exercisable in cash and/or in<br />

new and/or existing <strong>France</strong> <strong>Tele<strong>com</strong></strong> shares was authorized to<br />

holders of <strong>Orange</strong> options having signed a liquidity contract. Said<br />

ILO are securities giving access to capital within the meaning of<br />

Article L. 228-91 of the French Commercial Code and which,<br />

when they are exercised, grant their holders the right to receive<br />

cash and/or existing shares and/or new shares, depending on<br />

the consideration taken into account by <strong>France</strong> <strong>Tele<strong>com</strong></strong>. The<br />

delegation granted under the seventeenth resolution of the<br />

Combined Shareholders’ Meeting of May 26, <strong>2009</strong> would be<br />

terminated with immediate effect, in this framework, for the nonused<br />

portion.<br />

Today, you are requested to renew the delegation granted to<br />

the Board of Directors so as to continue, where applicable,<br />

the implementation of option-related liquidity instruments for<br />

holders of <strong>Orange</strong> subscription options not eligible for the initial<br />

allocation of 2005, as they had not signed a liquidity contract<br />

at said date. It is specifi ed that the amounts to be paid or the<br />

number of <strong>France</strong> <strong>Tele<strong>com</strong></strong> shares to be issued on said account<br />

shall not differ from those provided for under the liquidity<br />

contracts existing on today’s date, subject to the method of<br />

calculating the amount of fractional shares.<br />

For these reasons, we request you:<br />

■ delegate to the Board of Directors, with right of delegation<br />

as provided for by law, for an eighteen month period as from<br />

the date of your Shareholders’ Meeting, the powers needed<br />

to carry out, on one or more occasions, in the proportion<br />

and at the times that it would decide, the issue and free<br />

allocation of option-related liquidity instruments for which,<br />

where applicable, the Company’s shares would be paid up in<br />

full by offsetting receivables;<br />

■ decide to cancel preferential subscription rights to said<br />

option-related liquidity instruments and to reserve the right<br />

to subscribe for same to holders of <strong>Orange</strong> S.A. share<br />

subscription options having entered into a liquidity contract<br />

with the Company.<br />

The maximum par value of the capital increase resulting from<br />

all issues that may be made under this delegation would be<br />

set at 1,000,000 euros, not factoring in adjustments that may<br />

be made to protect the interests of the signatories of liquidity<br />

contracts in accordance with current laws and regulations<br />

and the applicable contractual terms. Said amount would be<br />

charged against the maximum amount of 3.5 billion euros<br />

set under the eighteenth resolution adopted by the Annual<br />

Shareholders’ Meeting of May 26, <strong>2009</strong>.<br />

The subscription price of shares issued upon exercise of<br />

option-related liquidity instruments would be calculated, the<br />

list of allottees would be set and the number of option-related<br />

liquidity instruments to be issued to each benefi ciary would be<br />

determined in accordance with the terms of the twelfth resolution<br />

proposed to your Shareholders’ Meeting.<br />

We also ask you to decide that the Board of Directors has all<br />

powers to implement this resolution.<br />

For these reasons, we request you to approve the<br />

twelfth resolution.<br />

Thirteenth resolution<br />

Allocation of subscription and/or purchase options<br />

of the Company’s shares (twentieth resolution)<br />

In the interest of overall consistency in relation to stock options<br />

for the entire Group, your Annual Shareholders’ Meeting of<br />

September 1, 2004 had authorized the Board of Directors to<br />

grant subscription and/or purchase options to the Company’s<br />

shares (fi fth resolution). Said authorization was renewed by<br />

the Annual Shareholders’ Meeting of May 21, 2007 (twentieth<br />

resolution). As said resolution soon expires, it is proposed that<br />

you adopt a new resolution and thus authorize, in accordance<br />

with Article L. 225-177 et seq. of the French Commercial Code,<br />

the Board of Directors to grant, on one or more occasions,<br />

subscription or purchase options to the Company’s shares in<br />

accordance with the terms hereinafter, including, in accordance<br />

with the corporate governance code of listed <strong>com</strong>panies,<br />

the performance criteria, the determining of which shall be<br />

delegated to the Board of Directors.<br />

The benefi ciaries must be employees or corporate offi cers<br />

(within the meaning of Article L. 225-185 (4) of the Company or<br />

<strong>com</strong>panies or consortiums affi liated to it within the meaning of<br />

Article L. 225-180 of the French Commercial Code. The Board<br />

of Directors may grant options to all or some of said persons.<br />

Said authorization would be granted for a thirty-eight month<br />

period as from the date of your Annual Shareholders’ Meeting.<br />

Each option would grant entitlement to the subscription or<br />

purchase of a new or existing share, as the case may be.<br />

The options that may be granted may not grant entitlement to<br />

the subscription or purchase of a number of shares representing,<br />

on the allocation date, more than 1% of the Company’s capital<br />

on the date of your Annual Shareholders’ Meeting.<br />

The Board of Directors shall set the exercise price of options<br />

granted under this resolution in accordance with the following<br />

terms and conditions:<br />

■ the exercise price may not be less than the average of the<br />

prices recorded over the twenty trading sessions prior to<br />

the date on which the options are granted. No option may<br />

be granted less than twenty trading session after a coupon<br />

granting a right to a dividend or a capital increase has been<br />

separated from the shares;<br />

550<br />

<strong>2009</strong> REGISTRATION DOCUMENT / FRANCE TELECOM

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!